Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today provided an update for current and prospective shareholders as it continues to make strong progress on its “Project Varin” initiative. Project Varin, designed to produce ultra-highly bioavailable exotic cannabinoids, launched earlier this year and, to date, has produced new cannabinoid production techniques, unique time-released polymeric nanoparticles and two novel patent filings. Cannabis Global is now implementing a program to produce commercially viable quantities for use in its own products to be released later this month. “While THC-V is found in very small quantities within the cannabis plant, extraction, isolation and purification is currently problematic and unreliable,” Cannabis Global CEO Arman Tabatabaei said in the news release. “For this reason, we have expanded our research and development programs to include ultra-pure manufactured THC-V. We expect our new THC-V products to not only be the first to market, but to also establish leadership relative to quality and purity with zero heavy metals, solvent residues, plant impurities and no chance of cannabinoid microbial and mold proliferation. Other manufacturers need to mitigate these issues, but with our technology, these simply cannot be issues as we completely avoid the processing steps where such impurities are introduced.”
To view the full press release, visit http://cnw.fm/hySX1
About Cannabis Global, Inc.
Cannabis Global, Inc. (MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.
NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire is part of the InvestorBrandNetwork.